mRNA |
CX-5461 |
GDSC1000 |
pan-cancer |
AAC |
0.093 |
0.01 |
mRNA |
Teniposide |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.01 |
mRNA |
selumetinib:piperlongumine (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.097 |
0.01 |
mRNA |
SRT-1720 |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.01 |
mRNA |
isonicotinohydroxamic acid |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.01 |
mRNA |
prima-1 |
CTRPv2 |
pan-cancer |
AAC |
0.085 |
0.01 |
mRNA |
KHS101 |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.01 |
mRNA |
Talazoparib |
GDSC1000 |
pan-cancer |
AAC |
0.097 |
0.01 |
mRNA |
Nilotinib |
CCLE |
pan-cancer |
AAC |
-0.14 |
0.01 |
mRNA |
RAF265 |
CCLE |
pan-cancer |
AAC |
-0.14 |
0.02 |